| Literature DB >> 26447691 |
Emilie L Laurin1, Shawn L B McKenna1, Javier Sanchez1, Horacio Bach2, Juan Carlos Rodriguez-Lecompte1, Marcelo Chaffer1, Greg P Keefe1.
Abstract
Although cell-mediated immunity based diagnostics can be integral assays for early detection of various diseases of dairy cows, processing of blood samples for these tests is time-sensitive, often within 24 hours of collection, to maintain white blood cell viability. Therefore, to improve utility and practicality of such assays, the objective of this study was to assess the use of a novel white blood cell preservation technology in whole bovine blood. Blood samples from ten healthy cows were each divided into an unpreserved control sample and a test sample preserved with commercially-available cell transport medium. Samples were maintained at room temperature and stimulated with the mitogens pokeweed and concanavalinA, as well as with interleukin-12 p40. Stimulation was completed on days 1, 5, and 8 post-sampling. Viability of white blood cells was assessed through interferon gamma production determined with a commercial enzyme linked immunosorbent assay. In addition, mononuclear cell viability was assessed with propidium iodide flow cytometry. Greater interferon gamma production was observed on days 5 and 8 post-collection in preserved samples, with both pokeweed and concanavalinA stimulating positive interferon gamma production on day 5 post-collection. A greater proportion of the amount of interferon gamma produced on day 1 continued to be produced on days 5 and 8 post-collection with concanavalinA stimulation (with or without interleukin 12) as compared to pokeweed stimulation. Additionally, viable mononuclear cells were still present at eight days post-collection, with a higher mean proportion detected at days 5 and 8 in all stimulated preserved samples. This practical and simple method to extend in vitro white blood cell viability could benefit the efficient utilization of cell-based blood tests in ruminants.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26447691 PMCID: PMC4598078 DOI: 10.1371/journal.pone.0140046
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Means, model estimates, and P-values for predictors of interest, predictor interactions, and variances for random effects.
| Factor or Effect | Range of Means |
| |
|---|---|---|---|
| Treatment (tx) | PBS (control) | 0.00 | <0.01 |
| Pokeweed | 0.53–254.12 (13.32–128.26) | - | |
| Concanavalin A | -0.72–31.10 (11.66–41.47) | - | |
| Concanavalin A + Interleukin-12 | -1.04–32.10 (16.58–42.67) | - | |
| Interleukin-12 | -1.42–0.35 (0.15–0.78) | - | |
| Preservation (tm) | 0.2 | <0.05 | |
| Day | - | <0.01 | |
| Interactions | tx X tm | - | <0.01 |
| tm X day | - | 0.01 | |
| tx X day | - | <0.01 | |
| tx X tm X day | - | 0.01 | |
| Variances | Between cow | 0.07 (23.6% | <0.05 |
| Between day | 0.01 (2.6%) | 0.33 | |
| Between preservation | 0.04 (12.0%) | <0.05 | |
| Residual (within cow) | 0.18 (61.8%) | <0.01 | |
a Estimates for treatments presented as a range of means over time.
b Estimates for treatments in unpreserved samples.
c Estimates for treatments in preserved samples.
d Proportion of total unexplained variance.
e P-value for complete treatment factor.
Change in sample to positive ratios of interferon gamma production over time (days).
On each day, this change was determined by comparing the use of a stimulant (pokeweed mitogen, PWM; concanavalin A, ConA; interleukin-12 p40 potentiated ConA, ConA+IL-12 p40; or IL-12 p40 alone) versus no stimulation (phosphate buffered saline) for white blood cells unpreserved or preserved with a transport medium (SCSR-T, NonInvasive Technologies) supplemented in whole blood samples from ten healthy cows.
| Unpreserved Blood | Preserved Blood | |||||
|---|---|---|---|---|---|---|
| Day | Day | |||||
| 1 | 5 | 8 | 1 | 5 | 8 | |
|
| 265.7 | 23.2 | -1.3 (9) [-6.6–4.0] | 95.8 | 19.9 | 6.1 (10) [-1.5–13.7] |
|
| 24.9 (10) [8.8–41.0] | 7.0 (9) [-1.5–15.6] | -1.8 (9) [-6.9–3.4] | 26.8 | 15.9 | 5.5 (10) [-1.9–12.8] |
|
| 23.8 | 6.7 (9) [-1.7–15.1] | -3.6 (8) [-8.5–1.3] | 30.3 | 13.5 | 6.9 (10) [-1.0–14.8] |
|
| -2.0 (10) [-7.0–2.9] | -0.4 (9) [-6.3–5.5] | 0.5 (8) [-5.6–6.5] | -0.9 (10) [-6.1–4.3] | 0.1 (10) [-5.7–5.9] | 0.6 (10) [-5.0–6.3] |
a Significantly different (P <0.01) sample to positive ratio compared to no stimulation (phosphate buffered saline) as determined by Bonferroni corrections of P-values for multiple comparisons.
b 95% confidence interval.
c Total number of observations.
Fig 1Propidium iodide flow cytometric analysis of viable and nonviable cells in preserved and unpreserved samples.
Results from day 8 of the sampling period are shown for whole blood samples, either preserved (panel a.) with a transport medium (TM; SCSR-T, NonInvasive Technologies) or unpreserved (panel b.), that were collected from ten healthy cows. Arrows identify areas representing viable and nonviable cells, with the percentage of cells measured labelled per quadrant. Representative samples shown were samples stimulated with interleukin-12 p40 potentiated concanavalinA (ConA+IL-12).
Fig 2Predicted average proportion of mononuclear cell viability (with 95% confidence intervals) over time (days).
Predicted results are shown for whole blood samples, either unpreserved or preserved with a transport medium (SCSR-T, NonInvasive Technologies), that were collected from ten healthy cows.